Check-Cap Ltd. (CHEK)

NASDAQ: CHEK · IEX Real-Time Price · USD
1.78
+0.23 (14.84%)
At close: Jun 2, 2023, 4:00 PM
1.85
+0.07 (4.04%)
After-hours: Jun 2, 2023, 7:52 PM EDT
14.84%
Market Cap 10.41M
Revenue (ttm) n/a
Net Income (ttm) -17.72M
Shares Out 5.85M
EPS (ttm) -3.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 72,000
Open 1.56
Previous Close 1.55
Day's Range 1.56 - 1.78
52-Week Range 1.22 - 9.20
Beta 0.39
Analysts Strong Buy
Price Target 7.00 (+293.26%)
Earnings Date May 11, 2023

About CHEK

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application tha... [Read more]

Sector Healthcare
IPO Date Feb 19, 2015
Employees 85
Stock Exchange NASDAQ
Ticker Symbol CHEK
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for CHEK stock is "Strong Buy" and the 12-month stock price forecast is $7.0.

Price Target
$7.0
(293.26% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Check-Cap Reports First Quarter 2023 Financial Results

ISFIYA, Israel , May 11, 2023 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first...

3 weeks ago - PRNewsWire

Check-Cap Reports Fourth Quarter and Full Year 2022 Financial Results

ISFIYA, Israel , March 31, 2023 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of...

2 months ago - PRNewsWire

Check-Cap Issues an Update to Shareholders

ISFIYA, Israel , March 21, 2023 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of...

2 months ago - PRNewsWire
}

Check-Cap Reports Third Quarter 2022 Financial Results and Provides a Corporate Update

ISFIYA, Israel , Nov. 30, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of ...

6 months ago - PRNewsWire

Check-Cap Reports Second Quarter 2022 Financial Results and Provides a Corporate Update

ISFIYA, Israel , Aug. 31, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of ...

9 months ago - PRNewsWire

Check-Cap Ltd. (NASDAQ: CHEK) Announces Receipt of Extension to Meet the Nasdaq's Minimum Bid Price Requirement

ISFIYA, Israel , June 23, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of ...

1 year ago - PRNewsWire

Check-Cap Reports First Quarter 2022 Financial Results and Corporate Update

Company initiated first part of its U.S. pivotal study in early May 2022 ISFIYA, Israel , June 1, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a ...

1 year ago - PRNewsWire

Check-Cap Announces Initiation of the U.S. Pivotal Trial

ISFIYA, Israel , May 11, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-...

1 year ago - PRNewsWire
}

Check-Cap Reports Fourth Quarter and Full Year 2021 Financial Results

Company anticipates initiation of the first part of its U.S. pivotal study in April 2022 ISFIYA, Israel , April 7, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (N...

1 year ago - PRNewsWire

Check-Cap Ltd. Announces $10 Million Registered Direct Offering

ISFIYA, Israel, March 1, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C...

1 year ago - PRNewsWire

FDA Gives Green To Check-Cap's Pivotal Study For Capsule-Based Colorectal Cancer Screening Test

The FDA has approved Check-Cap Ltd's (NASDAQ: CHEK) amended Investigational Device Exemption (IDE) application to initiate the U.S. pivotal study of C-Scan. The U.S. pivotal study consists of two part...

1 year ago - Benzinga

Check-Cap Announces FDA Approval of Amended IDE Application for Pivotal Study of C-Scan

ISFIYA, Israel, Feb. 7, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-...

1 year ago - PRNewsWire

Check-Cap Issues Letter to Shareholders

ISFIYA, Israel, Jan. 5, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-...

1 year ago - PRNewsWire
}

Check-Cap Announces Receipt of Nasdaq Minimum Bid Price Notification

ISFIYA, Israel, Dec. 23, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C...

1 year ago - PRNewsWire

Check-Cap Announces Publication of Peer-Reviewed Article Highlighting Safety and Patient Satisfaction Data for its Colorectal Screening Test, C-Scan®

ISFIYA, Israel, Nov. 22, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C...

1 year ago - PRNewsWire

Check-Cap Reports Third Quarter 2021 Financial Results and Corporate Update

ISFIYA, Israel, Nov. 3, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-...

1 year ago - PRNewsWire

Check-Cap Announces Grant of Patent Covering C-Scan's Proprietary Tracking Technology in the U.S. and Additional Major Market Territories

ISFIYA, Israel, Nov. 2, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-S...

1 year ago - PRNewsWire

Check-Cap Announces Expansion of Manufacturing Capacity and Production Line to Support U.S. Pivotal Study Initiation

ISFIYA, Israel, Oct. 18, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C...

1 year ago - PRNewsWire

Check-Cap Appoints Dr. Hanit Brenner-Lavie as Vice President of Clinical Affairs

ISFIYA, Israel, Sept. 1, 2021 /PRNewswire/ -- Check-Cap Ltd.

1 year ago - PRNewsWire

Check-Cap Reports Second Quarter 2021 Financial Results and Corporate Update

ISFIYA, Israel, Aug. 5, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-...

1 year ago - PRNewsWire

Check-Cap Ltd. Announces $35 Million Registered Direct Offering

ISFIYA, Israel, June 30, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C...

2 years ago - PRNewsWire

Check-Cap Reports First Quarter 2021 Financial Results and Corporate Update

ISFIYA, Israel, May 12, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-...

2 years ago - PRNewsWire

Check-Cap Reports Fourth Quarter and Full Year 2020 Financial Results

ISFIYA, Israel, March 19, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of ...

2 years ago - PRNewsWire

FDA Signs Off Check-Cap's Pivotal Study For Capsule-Based Colorectal Cancer Screening Technology

Check-Cap Ltd (NASDAQ: CHEK) stock is moving higher on heavy volume in the premarket session after the FDA approved its Investigational Device Exemption (IDE) application, permitting Check-Cap to begi...

2 years ago - Benzinga

Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan®

ISFIYA, Israel, March 15, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of ...

2 years ago - PRNewsWire